Dr. Rao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1725 W Harrison St
Suite 1010
Chicago, IL 60612Phone+1 312-942-5904- Is this information wrong?
Education & Training
Rush University Medical CenterFellowship, Hematology and Medical Oncology, 2002 - 2005
University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 2000 - 2002
University of Southern California/LAC+USC Medical CenterResidency, Internal Medicine, 1999 - 2000- University of Southern California/LACUSC Medical CenterInternship, Transitional Year, 1998 - 1999
University of Wisconsin School of Medicine & Public HealthClass of 1998
Certifications & Licensure
IL State Medical License 2000 - 2026- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Phase II Open-Label Trial of Tarceva in Women With Metastatic, Hormone- and HER2-Negative Breast Cancer Start of enrollment: 2007 Apr 01
- A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer Start of enrollment: 2021 May 10
- A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer Start of enrollment: 2021 Oct 04
Publications & Presentations
PubMed
- Correction: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin‑treated breast cancer patients: a prospective exploratory study.Wei, C., Banach, K., Chu, J., Tung, L., Atallah, I., Cobleigh, M., Rao, R., Feinstein, S., Usha, L., Reiser, J., Okwuosa, T.> ;Cardio-Oncology. 2024 Feb 6
- Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique.Emily J Gallagher, Heather Moore, Mario E Lacouture, Susan F Dent, Azeez Farooki, Marcus D Goncalves, Claudine Isaacs, Abigail Johnston, Dejan Juric, Zoe Quandt, Laura...> ;NPJ Breast Cancer. 2024 Jan 31
- 1 citationsSoluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study.Wei, C., Banach, K., Chu, J., Tung, L., Cobleigh, M., Rao, R., Feinstein, S., Usha, L., Reiser, J., Okwuosa, T., Atallah, I.> ;Cardio-Oncology. 2024 Jan 15
- Join now to see all
Journal Articles
- Gestational Breast Cancer: Current Challenges in Staging and Treatment of Breast CancerRuta Rao, MD, BMJ Case Reports CP
Press Mentions
5 Breast Cancer FactsOctober 1st, 2022
Dr. Janet Wolter, Pioneering Oncologist, at Rush University Medical Center, Dead at 93February 10th, 2020
OncLive® Presents State of the Science SummitFebruary 28th, 2019- Join now to see all
Hospital Affiliations
Rush University Medical CenterChicago, Illinois
Rush Oak Park HospitalOak Park, Illinois
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
